NEW YORK (
CHANGE IN RATINGS, EPS
numbers raised at Goldman. Shares of ABT now seen reaching $59. Estimates also increased, to match the company's new guidance. Neutral rating.
is upgraded to buy at TheStreet Ratings.
upgraded at JP Morgan to Overweight. Agriculture fundamentals are robust.
(AXP - Get Report)
removed from Top Picks at Citigroup. Shares of AXP now seen reaching $58. Estimates also lowered on Europe softness. Maintain Buy rating.
American Express estimates cut at Goldman through 2013. Company is releasing fewer reserves. Buy rating and $56 price target.
estimates, target lowered at Citigroup. Shares of APH now seen reaching $51. Estimates also lowered as defense spending trends remain clouded due to Washington. Buy rating.
Amphenol estimates, target cut at Credit Suisse. Shares of APH now seen reaching $49. Estimates also reduced, given weaker end-market demand. Outperform rating.
Amphenol estimates, target lowered at UBS. Shares of APH now seen reaching $46. Estimates also lowered as 4Q outlook impacted by Telecom/IT Datacom. Neutral rating.
estimates, target increased at Citigroup. Shares of APOL now seen reaching $50. Estimates also raised on positive outlook and regulatory concerns waning. Neutral rating.
Apollo estimates, target raised at Credit Suisse. Shares of APOL now seen reaching $52. Estimates also increased, given higher growth in starts. Outperform rating.
(BLK - Get Report)
estimates increased at Citigroup through 2012. NAVs partially offset by lower ST flows. Maintain $180 price target and Buy rating.
BlackRock estimates, target reduced at Credit Suisse. Shares of BLK now seen reaching $194. Estimates also cut, given lower net flows. Outperform rating.
downgraded at Ticonderoga from Buy to Neutral. Slower end-market demand could hurt growth. Company is also highly leveraged to Research in Motion.
numbers cut at Credit Suisse. Shares of CAKE now seen reaching $30. Estimates also reduced, as the company is struggling to leverage higher sales. Neutral rating.
Chesapeake Energy rated new Buy at Sterne Agee. CHK was initiated with a Buy rating. $40 price target. Company is cutting debt and liquids business should drive growth.
downgraded at Goldman to Neutral. Valuation call.